1346674-21-2

Basic information

• Product Name: ethyl 1-(cyanomethyl)-5,5-dimethyl-1,4,5,6-tetrahydrocyclo-penta[b]pyrrole-2-carboxylate
• CAS NO: 1346674-21-2
• Molecular Weight: 246.309
• Mol File: 1346674-21-2.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 402.7±45.0 °C(Predicted)
• Density: 1.14±0.1 g/cm3(Predicted)
• CAS DataBase Reference: ethyl 1-(cyanomethyl)-5,5-dimethyl-1,4,5,6-tetrahydrocyclo-penta[b]pyrrole-2-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 1-(cyanomethyl)-5,5-dimethyl-1,4,5,6-tetrahydrocyclo-penta[b]pyrrole-2-carboxylate(1346674-21-2)
• EPA Substance Registry System: ethyl 1-(cyanomethyl)-5,5-dimethyl-1,4,5,6-tetrahydrocyclo-penta[b]pyrrole-2-carboxylate(1346674-21-2)

Safety Data

• Hazardous Substances Data: 1346674-21-2(Hazardous Substances Data)

Upstream product

• 1346674-19-8 (E)-ethyl 3-(2-Chloro-4,4-dimethylcyclopent-1-enyl)acrylate 
• 1346672-63-6 2-chloro-4,4- dimethylcyclopent-1-ene-1-carbaldehyde 
• 2758-18-1 3-Methyl-2-cyclopenten-1-one 
• 20500-49-6 3,3-dimethylcyclopentanone 
• 1346674-20-1 ethyl 5,5-dimethyl-1,4,5,6-tetrahydrocyclopenta[b]pyrrole-2-carboxylate 
• 590-17-0 cyanomethyl bromide 

Downstream Products

• 1346674-24-5 2-bromo-6-(7,7-dimethyl-1-oxo-3,4,7,8-tetrahydro-1H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-2(6H)-yl)benzyl acetate 
• 1346674-25-6 10-[2-(acetoxymethyl)-3-[1-methyl-6-oxo-5-(pyrimidin-4-ylamino)-1,6-dihydropyridin-3-yl]phenyl]-4,4-dimethyl-1,10-diazatricyclo[6.4.0.0(2,6)]dodeca-⁽⁶⁾,7-dien-9-one 
• 1346670-16-3 10-[2-(hydroxymethyl)-3-[1-methyl-6-oxo-5-(pyrimidin-4-ylamino)-1,6-dihydropyridin-3-yl]phenyl]-4,4-dimethyl-1,10-diazatricyclo[6.4.0.0(2,6)]dodeca-2⁽⁶⁾,7-dien-9-one 
• 1434050-55-1 4-chloro-2-{4,4-dimethyl-9-oxo-1,10-diazatricyclo[6.4.0.0^2,6]dodeca-2⁽⁶⁾,7-dien-10-yl}pyridine-3-carbaldehyde 
• 1346674-61-0 2-bromo-4-fluoro-6-(9-oxo-4,4-dimethyl-1,10diazatricyclo[6.4.0.0^2,6]dodeca-2⁽⁶⁾,7-dien-10-yl)benzyl acetate 
• 1433990-52-3 2-bromo-6-{4,4-dimethyl-9-oxo-1,10-diazatricyclo[6.4.0.0^2,6]dodeca-2⁽⁶⁾, 7-dien-10-yl}-4-fluoro-N-methylbenzamide 
• 1433990-51-2 2-bromo-6-{4,4-dimethyl-9-oxo-1,10-diazatricyclo[6.4.0.0^2,6]dodeca-2⁽⁶⁾,7-dien-10-yl}-4-fluorobenzoic Acid 
• 1433990-49-8 2-bromo-6-{4,4-dimethyl-9-oxo-1,10-diazatricyclo[6.4.0.0^2,6]dodeca-2⁽⁶⁾,7-dien-10-yl}-4-fluorobenzaldehyde 
• 1346675-25-9 2-(7,7-dimethyl-1-oxo-3,4,7,8-tetrahydro-1H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-2(6H)-yl)-4-fluoro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl acetate 

Relevant articles and documents

2-OXO-IMIDAZOPYRIDINES AS REVERSIBLE BTK INHIBITORS AND USES THEREOF

The present invention relates to imidazo pyridine compounds, and pharmaceutically acceptable compositions thereof, useful as BTK inhibitors.

PYRAZOLE CARBOXAMIDE COMPOUNDS FOR USE IN THE TREAMENT OF DISORDERS MEDIATED BY BRUTON'S TYROSINE KINASE (BTK)

Pyrazole carboxamide compounds of Formula (I) are provided (X and R1-R6 are as defined in the claims), with various substituents, and including stereoisomers, tautomers, and pharmaceutically acceptable salts thereof, useful for inhib

ALKYLATED PIPERAZINE COMPOUNDS

Alkylated piperazine compounds of Formula I are provided, including stereoisomers, tautomers, and pharmaceutically acceptable salts thereof, useful for inhibiting Btk kinase, and for treating immune disorders such as inflammation mediated by Btk kinase. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, and treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.